Tag: artificial-intelligence

Metaverse in Education Market Benefits from Rising Demand for Lifelong Learning

The global metaverse in education market size was estimated at USD 4,375,184.4 million in 2023 and is projected to reach USD 41,622,011.6 million by 2030, growing at a CAGR of 38% from 2024 to 2030. This remarkable growth is primarily driven by factors such as the increasing popularity of experiential learning, improved technological accessibility, heightened demand for interactive education, and continuous advancements in immersive technologies.

The metaverse introduces vast opportunities for students to engage in deeply immersive simulations and virtual recreations, enabling them to explore historical events and perform scientific experiments in lifelike digital environments. These platforms also facilitate global collaboration, allowing students from different regions to engage in joint projects, share ideas, and problem-solve together in real time, thereby encouraging a more inclusive and interactive learning atmosphere.

Educational institutions are under growing pressure to deliver high-quality, tech-enhanced educational experiences. The core objective behind integrating emerging technologies into education is to enhance accessibility and student engagement. Extended reality (XR) technologies, such as virtual reality (VR) and augmented reality (AR), improve learning outcomes by delivering realistic and interactive content that reduces cognitive load and boosts comprehension. Institutions are increasingly investing in VR solutions for both in-person and online learning to enrich student experiences, including virtual field trips, company tours, and museum explorations.

The metaverse also has the potential to democratize education. Students with internet access, regardless of geographical constraints or physical disabilities, can immerse themselves in virtual learning environments. As VR and AR technologies become more cost-effective and widely available, their integration into classrooms is expected to grow substantially. Traditional teaching methods are being supplemented, and in some cases replaced, by more interactive and tailored learning experiences within the metaverse, aligning with various learning styles and keeping students actively engaged.

Order a free sample PDF of the Metaverse In Education Market Intelligence Study, published by Grand View Research.

Key Market Trends & Insights

  • By Region: North America was the largest revenue-generating region in 2023.
  • By Segment: Hardware generated USD 4,375,184.4 million in revenue in 2023 and is expected to be the fastest-growing segment during the forecast period.

Market Size & Forecast

  • 2023 Market Size: USD 4,375,184.4 million
  • 2030 Projected Market Size: USD 41,622,011.6 million
  • CAGR (2024–2030): 38%
  • North America: Largest market in 2023

Key Metaverse in Education Companies

Leading companies driving the metaverse in education market include:

  • Adobe Inc.
  • Baidu Inc.
  • Epic Games
  • HP Inc.
  • Lenovo
  • Meta
  • Microsoft Corporation
  • Roblox Corporation
  • Samsung Electronics
  • Unity Software Inc.

These companies are focusing on expanding their customer base and gaining a competitive advantage through strategic moves such as collaborations, mergers & acquisitions, and new product innovations. For example, in September 2023, Meta collaborated with 15 U.S. universities to deliver VR-based courses, emphasizing soft skills and real-world simulation experiences. Participants include institutions like Stanford University, Morehouse College, and the University of Iowa.

Explore Horizon Databook – The world’s most expansive market intelligence platform developed by Grand View Research.

Conclusion

The metaverse is revolutionizing the education sector by enabling immersive, accessible, and collaborative learning experiences. With institutions increasingly investing in XR technologies and students seeking more engaging educational formats, the metaverse in education market is poised for exponential growth. As companies continue innovating and educational paradigms shift towards virtual learning environments, the metaverse is set to become a foundational component of future education systems worldwide.

Recommendation Engine Market Supported by Growth in Mobile Application Integration

The global recommendation engine market was valued at USD 3.92 billion in 2023 and is expected to expand at a compound annual growth rate (CAGR) of 36.3% from 2024 to 2030. As organizations increasingly focus on improving customer experiences and optimizing operations, recommendation engines have become vital tools. Utilizing advanced algorithms, including machine learning (ML) and artificial intelligence (AI), these engines process vast datasets to deliver personalized recommendations to users. This functionality is particularly valuable in industries like e-commerce, media and entertainment, and healthcare, where tailored experiences can greatly enhance customer satisfaction and loyalty.

The rising demand to improve customer experiences is driving the adoption of recommendation engines. Additionally, the growing embrace of digital technologies across organizations is contributing to the increasing demand for these solutions. The COVID-19 pandemic significantly disrupted various industries, reshaping business operations and consumer shopping behaviors—trends that are expected to continue beyond the pandemic. For example, e-commerce giant Amazon.com, Inc. generated approximately USD 33 million in sales per hour during the first quarter of 2020.

Deployment Insights

In 2023, the cloud deployment segment led the market, accounting for 87.7% of the share. Cloud-based recommendation engines enable businesses to scale efficiently, managing increasing data volumes and user numbers without requiring major infrastructure investments. This scalability is particularly advantageous for e-commerce platforms and streaming services that face fluctuating traffic and need to consistently deliver high-quality recommendations. Additionally, cloud deployment reduces reliance on on-premises hardware and maintenance, lowering capital expenditures. The pay-as-you-go pricing model also offers a cost-effective approach, aligning expenses with actual usage and benefiting businesses of all sizes.

Organization Insights

Large enterprises dominated the market in 2023, driven by the need to make informed decisions, effectively manage business portfolios, and maintain a competitive advantage globally. These enterprises leverage recommendation engines to process vast customer data and provide personalized recommendations. Furthermore, integrating AI and ML technologies enhances data analysis and recommendation accuracy, enabling large enterprises to deliver superior customer experiences and stay ahead of competitors.

Get a preview of the latest developments in the Recommendation Engine Market! Download your FREE sample PDF today and explore key data and trends

Application Insights

The personalized campaigns and customer delivery segment held the largest revenue share in 2023, accounting for 42.0% of the market. This dominance is attributed to the increasing focus on improving customer experiences. Businesses across industries such as e-commerce, media, and financial services have adopted recommendation engines to execute personalized marketing campaigns and tailored customer interactions. These engines enable highly targeted marketing efforts, fostering stronger customer relationships, enhancing engagement, and boosting customer loyalty.

End-use Insights

The retail segment led the market in 2023, capturing 25.0% of the share. This growth is driven by the rapid digital transformation within the retail sector, leading to widespread adoption of recommendation engines to improve customer experience and engagement. Retailers are leveraging these tools to offer personalized product recommendations, thereby enhancing customer satisfaction and increasing sales and conversion rates. The expansion of e-commerce platforms has further accelerated this trend, as online retailers seek to differentiate themselves through customized shopping experiences in a highly competitive landscape.

Regional Insights

North America held a 32.0% market share in 2023, fueled by the widespread adoption of over-the-top (OTT) services, particularly in video and audio streaming. Platforms such as Netflix, Hulu, and Spotify rely heavily on recommendation engines to suggest content based on users’ viewing and listening habits. This personalized approach is critical for retaining subscribers and maintaining engagement in a fiercely competitive market.

Key Players in the Recommendation Engine Market

The following companies are the major players shaping the recommendation engine market, holding significant market shares and influencing industry trends:

• Adobe
• Amazon Web Services, Inc.
• Google LLC
• Hewlett Packard Enterprise Development LP
• International Business Machines Corporation
• Intel Corporation
• Microsoft Corporation
• Oracle
• Salesforce, Inc.
• SAP SE

Gather more insights about the market drivers, restrains and growth of the Recommendation Engine Market

Bioanalytical Testing Services Market Fueled by Increasing Focus on Biomarker Testing

The global bioanalytical testing services market was valued at USD 4.73 billion in 2024 and is anticipated to expand at a CAGR of 9.21% from 2025 to 2030. This growth is driven by the rising volume of drug development activities, increasing drug approval processes, growing therapeutic complexity, and a surge in outsourcing of testing services. The emergence of complex therapeutic modalities—such as gene therapies and biologics—has heightened the demand for specialized bioanalytical testing services. Additionally, technological advancements and rising investments in research and development are key contributors to market expansion.

The continuous evolution of advanced technologies—including High-Throughput Screening (HTS), Liquid Chromatography-Mass Spectrometry (LC-MS), and Next-Generation Sequencing (NGS)—has significantly enhanced the accuracy, speed, and sensitivity of bioanalytical testing. These innovations empower service providers to conduct more sophisticated studies and obtain precise data regarding drug efficacy, safety, pharmacokinetics, and more. Furthermore, the integration of automation and Artificial Intelligence (AI) within bioanalytical workflows has streamlined operations, minimized human error, and boosted throughput.

Moreover, heightened regulatory oversight and growing awareness of the critical role of bioanalytical testing are also fueling demand for these services. The implementation of stricter guidelines governing drug development—especially in pharmacokinetics, pharmacodynamics, and bioequivalence testing—by regulatory agencies like the U.S. FDA and EMA has led to a stronger inclination toward outsourcing. These regulations emphasize the necessity for accurate, reliable bioanalytical methods to ensure the safety and effectiveness of new drugs and biosimilars.

Pricing Analysis

The bioanalytical testing services sector utilizes various pricing models tailored to specific project requirements and levels of client engagement. Milestone-based pricing is widely adopted for projects with clearly defined stages, such as method development and sample analysis, enabling payments to be linked with the achievement of deliverables. This approach provides predictability for sponsors while aligning payments with progress for service providers. Fixed-fee pricing is more suitable for routine testing services—including bioequivalence and pharmacokinetic studies—where standardization leads to minimal variability.

Get a preview of the latest developments in the Bioanalytical Testing Services Market! Download your FREE sample PDF today and explore key data and trends

Molecule Insights

The small molecule segment held the largest market share at 55.3% in 2024. This dominance is attributed to breakthroughs in small molecule therapeutics and persistent unmet medical needs. Bioanalytical testing of small molecules plays a pivotal role in understanding their ADME (Absorption, Distribution, Metabolism, and Excretion) profiles, determining appropriate dosing, evaluating therapeutic efficacy, and ensuring patient safety.

Test Insights

In 2024, the bioavailability segment led the market. Its growth stems from its vital role in drug development and regulatory approval processes. Bioavailability studies are essential for assessing how effectively and rapidly a drug reaches systemic circulation, directly impacting dosage formulation, therapeutic efficacy, and safety. This segment is crucial for evaluating both new chemical entities and generic formulations to ensure consistent performance and compliance with bioequivalence standards.

Workflow Insights

The sample analysis segment was the dominant workflow category in 2024. This segment encompasses processes such as quantification of active pharmaceutical ingredients, metabolite detection, and stability testing—each critical for regulatory submissions and clinical trial advancement. As drug pipelines become more complex, especially with the rise of biologics and targeted therapies, demand for accurate, high-throughput sample analysis is expected to increase.

End Use Insights

In 2024, the pharma & biopharma companies segment accounted for the largest market share. This growth reflects the increasing reliance on outsourcing specialized testing throughout the drug development lifecycle. Pharmaceutical and biopharmaceutical companies are increasingly turning to external service providers to navigate the complex, highly regulated bioanalytical workflows—including pharmacokinetic assessments, immunogenicity testing, and biomarker validation. Outsourcing enables these companies to accelerate development timelines, reduce internal infrastructure costs, and access specialized expertise and advanced technologies.

Regional Insights

North America represented the largest share of the global bioanalytical testing services market, accounting for 47.40% in 2024. Growth in this region is propelled by rising demand for biopharmaceuticals, continuous technological innovation, and increased R&D investment in novel drug development. Advancements in mass spectrometry, chromatography, and other analytical techniques have further improved the sensitivity, specificity, and throughput of bioanalytical testing. These innovations enable laboratories to conduct more precise and efficient analyses, supporting faster drug development timelines and lowering costs.

Leading Companies in the Bioanalytical Testing Services Market

The following companies are key players in the bioanalytical testing services market, collectively holding a significant share and shaping industry trends:

  • Thermo Fisher Scientific Inc.
  • ICON Plc
  • Charles River Laboratories International
  • IQVIA Inc.
  • Syneos Health
  • SGS SA
  • Labcorp
  • Intertek Group Plc
  • Pace Analytical Services LLC
  • WuXi AppTec

Gather more insights about the market drivers, restrains and growth of the Bioanalytical Testing Services Market

Pathology Laboratories Market Gains Momentum with Increasing Cancer Screening

The global pathology laboratories market was valued at USD 386.18 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.1% from 2025 to 2030. This growth is primarily fueled by the expansion of healthcare facilities in developing regions, rising demand for routine medical examinations, and improvements in reimbursement policies for diagnostic tests. Additional drivers include an aging global population and the increasing prevalence of chronic diseases. Moreover, the market is benefiting from the establishment of new laboratories in emerging markets. For example, in August 2024, Neuberg Diagnostics launched a new laboratory facility in Puducherry, India, offering radiology, wellness, and pathology services.

As chronic diseases become more widespread, the demand for robust healthcare systems and timely diagnostics continues to rise. Early and accurate diagnosis is essential for effective management of chronic conditions, leading to greater reliance on clinical diagnostics. According to the World Health Organization, the global senior population is expected to increase from 1 billion in 2020 to 1.5 billion by 2030, with one in six people worldwide aged 60 or older. Chronic illnesses are especially common among older adults; the National Council on Aging reports that 80% of U.S. adults aged 65 and above have at least one chronic condition, emphasizing the critical need for regular health screenings in this age group.

The trend toward routine health check-ups is also on the rise. Given the high incidence of chronic conditions, individuals over 40 are strongly encouraged to undergo regular health screenings. Meanwhile, the growing occurrence of chronic diseases among younger adults has led to increased demand for preventive check-ups within this demographic. Heightened health awareness has motivated more individuals to prioritize routine medical evaluations.

In addition, many countries require employers to provide annual health assessments for their employees, creating further demand for diagnostic laboratory services. Increased healthcare spending aimed at improving infrastructure in developing nations has also contributed to the establishment of new hospitals and diagnostic labs, along with upgrades to existing facilities. For instance, in March 2022, the Delhi government announced plans to upgrade 15 hospitals and build four new hospitals in the city, boosting the expansion of hospital-based diagnostic centers.

Type Insights
In 2024, the hospital-based segment led the market, accounting for 55.7% of total revenue. The growth of hospital-based laboratories is driven by several factors: the rising burden of chronic diseases necessitating prompt and accurate diagnostics; technological advancements that enhance testing efficiency and accuracy; and the growing emphasis on patient-centered care, encouraging integration of laboratory services with clinical operations to improve outcomes. Furthermore, favorable reimbursement policies and the increasing demand for routine health screenings continue to support the expansion of hospital-based labs within healthcare systems.

Testing Services Insights
The general physiological and clinical tests segment held the largest market share in 2024, representing 39.2% of the total. These tests—including blood counts, metabolic panels, and urinalysis—are fundamental tools for diagnosing diverse health conditions and monitoring patient health. Their broad use across primary care, outpatient clinics, and hospitals sustains steady demand, as they are vital for early disease detection and effective treatment planning.

Get a preview of the latest developments in the Global Pathology Laboratories Market! Download your FREE sample PDF today and explore key data and trends

End-use Insights
In 2024, physician referrals accounted for 51.7% of the overall market share. Approximately 70% of physicians’ medical decisions depend on diagnostic and pathological test results, underscoring the critical role of laboratory testing in clinical decision-making. The increasing prevalence of targeted diseases across various age groups is expected to further drive the growth of this segment.

Regional Insights
North America dominated the global pathology laboratories market in 2024, capturing a 37.87% revenue share. The region’s leadership is attributed to its advanced healthcare infrastructure, high adoption of innovative diagnostic technologies, and well-established regulatory environment. Additionally, rising rates of chronic diseases, growing demand for personalized medicine, and increasing healthcare expenditures contribute to North America’s prominent position in the global market.

Key Pathology Laboratories Companies
The leading companies shaping the pathology laboratories market include:

  • Quest Diagnostics Incorporated
  • Eurofins Scientific
  • Laboratory Corporation of America Holdings
  • Exact Sciences Laboratories LLC
  • Spectra Laboratories
  • SYNLAB International GmbH
  • Sonic Healthcare Limited
  • Dr. Lal Path Labs
  • Metropolis Healthcare
  • Kingmed Diagnostics
  • Healius Limited
  • BioReference
  • Centro de Diagnósticos
  • Falco Holdings
  • Unilabs

Gather more insights about the market drivers, restrains and growth of the Pathology Laboratories Market

Medical Equipment Maintenance Market Driven by Strict Regulatory Compliance Needs

The global medical equipment maintenance market was valued at USD 41.90 billion in 2023 and is projected to expand at a CAGR of 10.0% from 2024 to 2030. The market’s growth is driven by the rising global demand for medical devices, the increasing prevalence of life-threatening conditions requiring diagnostic procedures, and the growing need for refurbished medical equipment.

Given the critical role of medical equipment in healthcare delivery, the effectiveness of treatments largely depends on the precision and performance of these devices. A wide range of equipment—such as electrocardiographs, syringe pumps, centrifuges, X-ray machines, autoclaves, and ultrasound devices—are used across healthcare settings for diagnosis and treatment. Due to continuous use, these devices require regular maintenance to address wear, malfunctions, and potential defects.

In 2023, imaging equipment led the market, accounting for 36.1% of total market share. Imaging devices are essential for visualizing internal body structures and facilitating accurate diagnosis. The rising incidence of chronic conditions, particularly cardiovascular diseases, is fueling demand in this segment. According to the Centers for Disease Control and Prevention, approximately 129 million people in the U.S. suffer from at least one major chronic disease. Common imaging modalities include X-rays, magnetic resonance imaging (MRI), computed tomography (CT) scans, and ultrasound.

Service Insights

The corrective maintenance segment held the largest revenue share in 2023. This segment focuses on repairing equipment following malfunctions or failures, restoring systems to their original working condition through replacement or restoration efforts. The increasing frequency of equipment breakdowns—stemming from constant use in modern healthcare facilities—is expected to drive rapid growth in this area.

Service Provider Insights

In 2023, the Original Equipment Manufacturer (OEM) segment captured the highest revenue share. OEMs provide highly specialized maintenance services tailored to their products, leveraging their deep understanding of the equipment’s design, components, and functionality. By offering post-warranty maintenance and repair services, OEMs not only generate additional revenue but also strengthen long-term relationships and foster customer loyalty.

Get a preview of the latest developments in the Global Medical Equipment Maintenance Market! Download your FREE sample PDF today and explore key data and trends

End-Use Insights

The hospital segment accounted for the largest revenue share in 2023. An aging global population is contributing to a rise in chronic diseases such as diabetes, heart disease, and cancer, driving the need for advanced diagnostic and therapeutic equipment. Private hospitals are investing in state-of-the-art devices to enhance patient care and attract more patients. Additionally, increased government spending on healthcare infrastructure continues to bolster the demand for sophisticated medical equipment.

Regional Insights

In 2023, North America dominated the global medical equipment maintenance market. Factors such as advancements in medical infrastructure, a growing burden of chronic illnesses, increased healthcare spending, and the presence of ambulatory surgical centers are fueling market growth in the region. North America’s strong healthcare sector and its growing role in medical tourism have sustained demand for reliable, fully operational medical equipment.

Leading Companies in the Medical Equipment Maintenance Market

The key players shaping the medical equipment maintenance market include:

  • GE HealthCare
  • Siemens Healthineers AG
  • Medtronic
  • Aramark
  • Koninklijke Philips N.V.
  • B. Braun SE
  • AlphaSource Group
  • Althea Group

Gather more insights about the market drivers, restrains and growth of the Medical Equipment Maintenance Market

Industry 4.0 Market Addresses Challenges in Legacy Systems Integration

The global Industry 4.0 market size is expected to reach USD 627.59 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to grow at a CAGR of 19.9% from 2023 to 2030. The growth of the market is attributed to the widespread adoption of the Internet of Things (IoT) devices and sensors, facilitating seamless data integration, while the infusion of Artificial Intelligence (AI) and Machine Learning (ML) is propelling predictive analytics and autonomous operations. Furthermore, the rising consumer spending on digitalization and cutting-edge factory solutions will increase demand for Industry 4.0 solutions.

Industry 4.0 emphasizes the creation of interconnected ecosystems where devices, machines, and systems communicate and collaborate seamlessly. This trend leads to streamlined information flow, enabling real-time decision-making based on accurate and up-to-date data. Edge computing, which processes data closer to its source, and cloud integration are trends supporting this interconnection. The deployment of Industry 4.0 solutions optimizes resource utilization, energy consumption, and overall process efficiency. With real-time data collection and analysis, companies gain insights into operational bottlenecks, allowing for timely adjustments and continuous improvement. Trends, such as digital twins (virtual replicas of physical assets), enable simulation and optimization of processes, thereby enhancing efficiency.

Order a free sample PDF of the Industry 4.0 Market Intelligence Study, published by Grand View Research.

The transition to Industry 4.0 requires a workforce with the necessary skills to operate and maintain advanced technologies. However, there is often a shortage of workers with expertise in data analytics, robotics, and cybersecurity. Businesses may need to invest in training and upskilling programs to ensure that their workforce can effectively leverage Industry 4.0 technologies. Implementing Industry 4.0 technologies often requires a significant upfront investment. The costs associated with acquiring and deploying advanced machinery, sensors, data analytics systems, and connectivity infrastructure can be substantial. Small and medium-sized enterprises (SMEs) may face financial constraints in adopting these technologies, limiting their ability to compete with more prominent industry players.

In the evolving market, the robotics and automation trend encompasses several transformative elements, including collaborative robots designed for safe human interaction and the integration of intelligent Robotic Process Automation (RPA) that streamlines repetitive tasks and processes. Advanced sensing and perception capabilities enable robots to interact more effectively with their environment, bolstering accuracy and adaptability. Furthermore, the infusion of AI and ML empowers robots to learn, adapt, and make real-time decisions, augmenting their problem-solving ability.

The North America regional market growth is driven by the need to address labor shortages and rising operational costs. Automation and robotics were integrated into manufacturing processes to perform repetitive tasks, reducing the reliance on manual labor. This shift not only improved efficiency but also enhanced workplace safety. With improved cost-effectiveness, regional manufacturers were better positioned to compete globally. IoT played a pivotal role by connecting devices and machinery to the internet, enabling real-time data collection and analysis. This data-driven approach allowed companies to monitor equipment performance, predict maintenance needs, and optimize production processes. The insights from IoT-powered analytics enhanced decision-making reduced downtime, and minimized resource wastage.

Industry 4.0 Market Report Highlights

  • Industry 4.0 marks the next phase of manufacturing digitization, driven by disruptive trends like connectivity, data, human-machine interaction, analytics, and robotics. It also includes the enhancement of manufacturing efficiency through the integration of technology and automation into both production and managerial workflows
  • The demand for IoT is increasing in most sectors, and the role played by solution providers and vendors is further contributing to its extravagant growth. Numerous initiatives at the industry level have been promoting and advertising IoT applications and their use cases
  • Industry 4.0 thrives on data collection and analysis. With the proliferation of sensors and connected devices, companies gather vast amounts of data that can be leveraged for informed decision-making
  • The consistent advancement of additive manufacturing technologies has led to heightened capabilities in terms of precision, speed, and scalability. Innovations in materials, printing techniques, and post-processing methods have collectively contributed to making 3D printing a feasible and effective solution across industries

List of Key Players in the Industry 4.0 Market

  • ABB Ltd.
  • Cisco System Inc.
  • Cognex Corporation
  • Denso Corporation
  • Emerson Electric
  • Fanuc Corporation
  • General Electric Company
  • Honeywell International Inc.
  • Intel Corporation
  • Johnson Controls International
  • Kuka Group
  • Robert Bosch GmbH
  • Rockwell Automation Inc.
  • Schneider Electric SE
  • Siemens AG

Gather more insights about the market drivers, restrains and growth of the Global Industry 4.0 Market

Patient Engagement Solutions Market Challenges: Addressing User Adoption and Trust Issues

The global patient engagement solutions market was valued at approximately USD 22.7 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 17.7% from 2024 to 2030. Key drivers for this growth include ongoing technological advancements, the increasing adoption of Electronic Health Records (EHR) and mobile health (mHealth) solutions, the rising prevalence of chronic diseases, supportive initiatives from major stakeholders, and a growing consumer focus on healthcare. A survey conducted by NextGen Healthcare in 2021 revealed that 83% of ambulatory healthcare providers believe that patient engagement solutions are essential for achieving both financial success and improved patient outcomes, with the COVID-19 pandemic further accelerating market growth.

Gather more insights about the market drivers, restrains and growth of the Global Patient Engagement Solutions Market

Segmentation Analysis:

Delivery Type Insights

In 2023, the web and cloud-based segment dominated the market, holding a substantial 78.0% revenue share, and is projected to experience the fastest growth throughout the forecast period. The increasing adoption of these solutions is attributed to their ability to provide remote access to real-time data tracking, integrated features, easy accessibility, low handling costs, and straightforward data backup. Consequently, companies are increasingly investing in web and cloud-based patient engagement solutions. For instance, Microsoft introduced Microsoft Cloud for Healthcare in May 2020, aiming to enhance patient engagement and facilitate collaboration among healthcare teams through telehealth and data analytics capabilities.

On-premise services also play a crucial role, offering secure patient data management and ease of access, driven by the desire for comprehensive information access within healthcare facilities.

Component Insights

The software and hardware segment accounted for the largest revenue share of 62.7% in 2023 and is anticipated to grow at the fastest CAGR over the forecast period. These components form the core offerings of patient engagement solutions, providing intuitive user interfaces and continuous product upgrades that simplify installation, usage, and record retrieval. An example is FollowMyHealth from Allscripts, a widely used mobile-first, customizable patient engagement solution that enhances care quality and patient satisfaction.

The services segment is essential for the effective operation of patient engagement solutions, aiding in their optimization based on customer needs and maximizing health outcomes. This segment encompasses consulting, implementation, training, support and maintenance, as well as services related to interoperability and access to EHR data.

Functionality Insights

In 2023, the communication segment held the largest revenue share at 35.0%, forming the foundational offering of any patient engagement solution. This dominance is driven by the growing demand for telehealth, mHealth, and various virtual communication channels, including audio, video, and text. The pandemic accelerated the adoption of these virtual communication solutions, extending their applications to remote patient monitoring and mental health services.

The health tracking and insights segment is projected to grow at the fastest rate of 19.1% over the forecast period, fueled by the increasing integration of data analytics, artificial intelligence (AI), and machine learning to provide actionable insights for patients and their healthcare providers. For instance, Nuance Communications, Inc. introduced Nuance Mix, a conversational AI platform utilizing deep learning-based speech and natural language understanding technologies. In September 2021, Leidos partnered with Nuance to incorporate this platform and its omnichannel development tools into custom patient engagement solutions.

End-use Insights

The providers segment captured the largest revenue share, exceeding 47.0% in 2023. Providers, who cater to the highest volume of patients and serve as the primary point of contact for health consultations, are the leading adopters of patient engagement solutions. For example, in December 2021, Northwell Health in the U.S. implemented a patient engagement platform by Playback Health at select clinical sites, promoting mobility and secure sharing of point-of-care medical data.

Conversely, the payers segment is expected to grow at the fastest rate of 18.0% during the forecast period. The expansion of this segment is attributed to the increasing adoption of patient and customer engagement solutions that enable broad coverage and support value-based care delivery. Payers are focusing on managing patient care and ensuring connectivity at every stage of the treatment process.

Therapeutic Area Insights

Chronic disease management dominated the market in 2023, holding a revenue share of over 44.7%. The growing geriatric population in key markets, along with the rising prevalence of chronic diseases and accelerated adoption of digital technologies driven by the COVID-19 pandemic, have significantly contributed to the segment’s large share. Patient engagement solutions facilitate chronic disease management by enabling prevention and detection of conditions and supporting both provider-led and self-management strategies.

The health and wellness segment is projected to experience the fastest growth rate of 18.0% over the forecast period, driven by initiatives from leading companies, an expansion of product offerings covering mental health, weight management, and pregnancy, as well as increased research activities. For instance, in June 2023, Cardinal Health finalized an agreement to transfer its Outcomes business to Transaction Data Systems, enhancing patient engagement and clinical pharmacy solutions, thereby strengthening connections between payers and pharmaceutical companies within its extensive pharmacy network.

Application Insights

Outpatient health management accounted for over 39.0% of the market share in 2023, highlighting its dominance. The segment encompassing research and development (R&D) and preventive care is expected to grow at the fastest rate of 18.0% throughout the forecast period. Patients with chronic conditions require continuous monitoring and updates regarding their health management. The rise of healthcare consumerism has also led patients to become more engaged in care planning, tracking, and optimization.

Patient engagement solutions enable remote connections between patients and their healthcare providers, facilitating the efficient exchange of information, patient feedback, and other health-related data. For example, in November 2019, the CDC funded 13 state-level arthritis management and prevention programs to enhance the quality of life and monitoring for rural arthritis patients. Additionally, the adoption of patient engagement solutions for R&D purposes by medical device manufacturers, pharmaceutical companies, and other life sciences entities is expected to grow significantly due to increasing product availability and demand.

Order a free sample PDF of the Patient Engagement Solutions Market Intelligence Study, published by Grand View Research.

Therapeutic Drug Monitoring Market Challenges: Overcoming Data Management Issues

The global therapeutic drug monitoring market size is estimated to reach USD 2.32 billion by 2030, expanding at a CAGR of 3.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. Recent technological advancements in the Point-of-Care (PoC) devices hold considerable transformative promises for the personalized predictive and preventive medicine. Therapeutic Drug Monitoring (TDM) forms a foundational part to the devising of personalized treatment plans for patients; and the advent of PoC diagnostic devices that yield quantitative measurements of the drug concentration plays a pivotal role in supporting the development of the precision medicine field in the healthcare sector. However, the broad application of the PoC devices for patient monitoring is still lagging behind. The presence of this untapped opportunity is one of the high impact rendering drivers for the market growth.

The employment of continuous therapeutic drug and metabolite monitoring in the early phase of the medication regimen, administered post-organ transplantation, forms a major application in the areas of critical care medicine and organ transplantation, which is expected to propel the growth of the therapeutic drug monitoring market over the forecast period. In addition, the imposing burden of diseases, such as epilepsy and cancer, the rising government initiatives, and the presence of high-unmet needs are some of the crucial determinants expected to further favor the emergence of this market.

Access the Therapeutic Drug Monitoring Market Size, Share & Trends Analysis Report By Product (Equipment, Consumables), By Drug Class (Antiarrhythmic Drugs), By End Use (Diagnostic Centers), By Region, And Segment Forecasts, 2024 – 2030

Therapeutic Drug Monitoring Market Report Highlights

The consumables segment covered over 65.4% of the market share in 2023 as a consequence of the extensive requirement of the consumables in the research laboratories and due to the repeat purchase of the kits and reagents.

The immunosuppressants segment is expected to grow fastest, with a compounded annual growth rate of 5.3% over the forecast period.

The hospital segment dominated the market share in 2023. In larger hospitals, various underlying technologies are employed to perform immunoassays; these comprise chemiluminescence, nephelometry, colorimetry, and fluorescence, which are available for the testing of a wide ranging drug panel.

The drug monitoring for the immunosuppressants is one of the fastest growing application segments owing to the introduction of novel TDM point-of-care testing devices for the evaluation of the concentration of administered immunosuppressants and the complementary metabolites, in order to achieve a prominent therapeutic effect while preventing drug toxicity events in patients that have undergone transplantations.

Key Therapeutic Drug Monitoring Company Insights

Some of the key companies in the therapeutic drug monitoring market are Abbott, ALPCO, Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Chromsystems Instruments & Chemicals GmbH, F.Hoffmann-La Roche Ltd., Randox laboratories Ltd, Siemens Healthineers AG., and biomérieux, Inc. Organizations are focusing on increasing customer base to gain a competitive edge in the industry. Therefore, key players are taking several strategic initiatives, such as mergers and acquisitions and partnerships with other major companies.

Abbott, known for its diagnostic technologies, offers a range of products and solutions tailored to monitor drug levels in patients effectively. These include assays and instruments that aid healthcare providers in optimizing medication dosages, ensuring efficacy, and enhancing patient safety across various therapeutic areas.

ALPCO (American Laboratory Products Company) is a player in the therapeutic drug monitoring market, specializing in providing high-quality assays and immunoassay kits. These products are designed to accurately measure drug levels in patient samples, supporting healthcare providers in optimizing therapeutic outcomes and patient management.

Order your free sample copy of “Therapeutic Drug Monitoring Market Report 2024 – 2030, published by Grand View Research

Key Therapeutic Drug Monitoring Companies:

The following are the leading companies in the therapeutic drug monitoring market. These companies collectively hold the largest market share and dictate industry trends.

  • Abbott
  • ALPCO
  • Beckman Coulter, Inc
  • Bio-Rad Laboratories, Inc
  • Thermo Fisher Scientific Inc.
  • Chromsystems Instruments & Chemicals GmbH
  • F.Hoffmann-La Roche Ltd.
  • Randox laboratories Ltd
  • Siemens Healthineers AG.
  • biomérieux, Inc.

About Grand View Research:

Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies, ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials, and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights. For more information, visit www.grandviewresearch.com

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058
Email:  sales@grandviewresearch.com

Hydrogel-based Drug Delivery System Market Key Insights: Navigating Emerging Trends

The global hydrogel-based drug delivery system market size is anticipated to reach USD 11.77 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.7% from 2024 to 2030. Hydrogels help in achieving spatial and temporal control over the release of the incorporated drug. Therefore, the surging demand for controlled releases drug delivery system across many therapeutic areas is a key factor expected to contribute to market growth during the forecast period.

Hydrogel-based drug delivery systems deliver the therapeutic drug directly at the target site and in a sustained manner. This can leverage beneficial outcomes such as improved efficacy, reduced side effects, and decreased dosage for patients and formulators. Hydrogel-based drug delivery systems are appealing and have been used in many branches of medicine such as oncology, pain management, immunology, cardiology, and wound management.

Access the Hydrogel-based Drug Delivery System Market Size, Share & Trends Analysis Report By Polymer Origin (Natural, Synthetic, Hybrid), By Delivery Route, By Region, And Segment Forecast, 2024 – 2030

The unique physical properties of hydrogel attract their interest in use for drug delivery applications. The porosity and drug loading capacity of hydrogels can be adjusted by modifying the density of cross-linking. This helps them to protect liable large drug molecules from degradation increasing the half-life. Many research studies have been carried out to examining the delivery of insulin orally using hydrogel systems. As patient compliance issues are frequently reported with injectable insulins such innovation is expected to be a disruptive technology in the diabetes care market.

There are numerous clinical studies underway specific to hydrogel-based drug delivery systems and various hydrogel technologies have already received regulatory approval for biomedical application. However, the technological challenges including the absence of defined regulatory guidelines, chemistry, complex manufacturing and control paraments, and practical adaptability are major roadblocks in the successful implementation in drug delivery use. For instance, the fabrication of hydrogel is complex and varies significantly depending upon the hydrogel systems.

Hydrogel-based Drug Delivery System Market Report Highlights

  • Based on polymer origin, the synthetic segment held the largest proportion of market share in 2023
  • The hybrid segment is expected to witness the fastest growth rate over the forecast period owing to the development of stimuli-responsive hydrogel technology
  • The synthetic segment is anticipated to grow fast over the forecast period compared to natural hydrogels due to their high drug loading capacity and improved mechanical strength
  • Based on delivery route, the ocular segment accounted for the largest revenue share in 2023
  • The subcutaneous segment is expected to grow at a healthy rate over the forecast period owing to the increasing number of clinical and pre-clinical studies carried out
  • North America holds the largest revenue share in this market due to the presence of key companies in the region doing R&D on specific hydrogel-based drug delivery systems
  • In Asia Pacific, the market is expected to grow at the fastest rate over the forecast period due to large patient base, improving healthcare infrastructure, and surging demand for modern therapies

Order your free sample copy of “Hydrogel-based Drug Delivery System Market Report 2024 – 2030, published by Grand View Research

Key Hydrogel-based Drug Based Delivery System Company Insights

Some key companies in the market include GALDERMA; Blairex Laboratories, Inc.; Johnson & Johnson; Bausch + Lomb; Medtronic; and Ocular Therapeutix, Inc. Vendors in the market are focusing on increasing their customer base to gain a competitive edge in the industry. Therefore, key players are taking several strategic initiatives, such as mergers and acquisitions, and partnerships with other emerging and prominent industry participants.

  • Ocular Therapeutix, Inc., is a biopharmaceutical company that specializes in creating, advancing, and marketing new treatments for eye disorders. It employs its own bioresorbable hydrogel-based formulation technology, ELUTYX. The company has manufacturing facilities in Massachusetts.
  • Blairex Laboratories, Inc., a global pharmaceutical company, delivers products related to the consumer and pharmaceutical industry. Some of the company’s major offerings are sterile saline solutions and contact lens care.

Key Hydrogel-based Drug Delivery System Companies:

The following are the leading companies in the hydrogel-based drug delivery system market. These companies collectively hold the largest market share and dictate industry trends.

  • GALDERMA
  • Blairex Laboratories, Inc
  • Johnson & Johnson
  • Bausch + Lomb.
  • Medtronic
  • Ocular Therapeutix, Inc.
  • Ferring B.V.
  • Endo, Inc.
  • Tolmar Inc

About Grand View Research:

Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies, ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials, and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights. For more information, visit www.grandviewresearch.com

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058
Email:  sales@grandviewresearch.com

Metaverse in Education Market Challenges: Overcoming Barriers to Adoption

The global metaverse in education market size is expected to reach USD 41.62 billion by 2030 and is anticipated to grow at a CAGR of 38.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market drivers include the growing popularity of experiential learning, the easy availability and adoption of Internet services, and the rising demand for interactive learning. The metaverse serves as a medium for various customers such as students to engage in engaging virtual presentations and real time learning experiences, to make them explore historical events, and to conduct scientific experiments in realistic environments. Moreover, these platforms can create virtual space, serving opportunities to connect with people located anywhere in the world and enhance their interactions, and problem-solving abilities among children. This further leads to a collaborative learning environment and can be especially beneficial for geographically dispersed students.

Educational organizations are facing several problems in the act of providing superior educational settings and tech-driven education to students.  Metaverse provides real time based technology to experience excellent learning experiences with the help of virtual presentations, thereby raising interactions among students and offering knowledge most interestingly. Various institutions are investing heavily in incorporating metaverse into their in-person and online courses to reduce cognitive burden.

The report “Metaverse in Education Market Size, Share & Trends Analysis Report By Component, By Application (Skill Development, Educational Apps), By End Use (Academic, Corporate), By Region, And Segment Forecasts, 2024 – 2030” is available now to Grand View Research customers and can also be purchased directly

Metaverse in Education Market Report Highlights:

  • The hardware segment led the market and accounted for over 47.0% share of the global revenue in 2023. Hardware manufacturers are constantly innovating to create VR headsets, AR glasses, and other devices that offer a more immersive and user-friendly experience
  • Based on application, the educational apps segment is predicted to grow at a significant CAGr from 2024 to 2030. The easy accessibility of educational apps on devices such as  tablets or smartphones makes them a more affordable entry point for schools and individual learners thereby increasing their demand
  • Based on end use, the academic segment accounted for the largest revenue share in 2023 owing to the more engaging and interactive learning environment offered by the metaverse,  motivates students to participate actively
  • North America dominated with a revenue share of over 35.0% in 2023. North America has a well-established EdTech industry with a history of innovation and investment in new learning technologies.

Order your free sample copy of “Metaverse In Education Market Report 2024 – 2030, published by Grand View Research

Metaverse in Education Market Segmentation:

Grand View Research has segmented the global metaverse in education market based on the component, application, end use, and region:

  • Metaverse in Education Component Outlook (Revenue, USD Billion, 2017-2030)
  • Hardware
    • AR Devices
    • VR Devices
    • MR Devices
    • Interactive Displays and Projectors
  • Software
    • Extended Reality Software
    • Gaming Engines
    • Metaverse Platforms
    • 3D Mapping, Modelling, and Reconstruction
  • Professional Services
    • Application Development and System Integration
    • Strategy & Business Consulting
  • Metaverse in Education Application Outlook (Revenue, USD Billion, 2017-2030)
  • Learning
  • Skill Development
  • Educational Apps
  • Self-Regulation Skills
  • Cultural Understanding
  • Others
  • Metaverse in Education End Use Outlook (Revenue, USD Billion, 2017-2030)
  • Academic
    • K-12
    • Higher Education
  • Corporate
  • Metaverse in Education Regional Outlook (Revenue, USD Billion, 2017-2030)
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Latin America
  • Brazil
  • MEA
  • UAE
  • South Africa
  • KSA

List of Key Players in the Metaverse in Education:

  • Adobe Inc.
  • Baidu Inc.
  • Epic Games
  • HP Inc.
  • Lenovo
  • Meta
  • Microsoft Corporation
  • Roblox Corporation
  • Samsung Electronics
  • Unity Software Inc.

About Grand View Research:

Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies, ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials, and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights. For more information, visit www.grandviewresearch.com

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058
Email:  sales@grandviewresearch.com

Design a site like this with WordPress.com
Get started